Follows people with severe tricuspid heart valve leakage after TricValve treatment
Follows patients with severe tricuspid regurgitation treated with the TricValve device over time.
Plain-language title generated from the registry record
Registry title: Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
Key facts
- Where
- Aalst, BelgiumSee the site
Where in Belgium
- Department of Cardiology, Algemeen Stedelijk Ziekenhuis (ASZ)Aalst, BelgiumNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- P+F Products + Features GmbH
- Trial code
- NCT05114850
- Record updated
- 3 April 2024
- Original description
Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.Read full original descriptionShow less
TRICUS REGISTRY - Retrospective Prospective Multicentric Clinical Follow up of Patients With Severe Tricuspid Regurgitation After Being Treated With the TricValve® Transcatheter Bicaval Valves System.
Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.
Inclusion: Successful treatment with TricValve Transcatheter Bicaval Valves System; Patient/patient's authorized legal guardian gives his consent to participate in the study and signed the corresponding inform consent.
Exclusion: no exclusion criterion.